Matthew Turner
About Matthew Turner
Matthew Turner is an Executive Territory Business Manager at Bristol-Myers Squibb, with extensive experience in the pharmaceutical and medical device industries.
Current Role at Bristol-Myers Squibb
Matthew Turner serves as the Executive Territory Business Manager at Bristol-Myers Squibb, focusing on the South Carolina and Georgia regions. In this role, he leverages his extensive experience in the pharmaceutical industry to manage territories, promote products, and establish productive relationships with key opinion leaders and specialty physicians. His efforts contribute to advancing the company's market presence and revenue growth within these states.
Previous Experience at Amgen
Matthew Turner worked as a Senior Biopharmaceutical Representative at Amgen, handling responsibilities in South Carolina and Georgia. His tenure at the company lasted for seven months from 2013 to 2014. During this period, he applied his expertise in biopharmaceuticals to drive product promotions and sales within his assigned territories.
Roles at Mylan Specialty
Matthew Turner was part of Mylan Specialty for several years, taking on progressive roles. From 2009 to 2013, he served as District Manager, covering North Carolina, South Carolina, Florida, and Georgia. Before that, he worked as a Sr. Specialty Representative from 2006 to 2009, focusing on South Carolina. His time at Mylan was marked by his ability to identify market niches, launch products, and significantly increase territory revenues.
Educational Background
Matthew Turner holds an MBA in Business Administration from Marshall University Graduate School of Management, completed between 2001 and 2003. He also earned a BS in Marketing/Economics from Marshall University, graduating in 2000. These academic credentials have provided a solid foundation for his career in business and pharmaceutical sales.
Therapeutic Expertise and Sales Achievements
Matthew Turner possesses therapeutic expertise in Rheumatology, Dermatology, Nephrology, Pulmonology, and Endocrinology, with a focus on infusion and self-injectable routes of delivery. He has a proven track record of being a top performer in medical device and pharma sales and has received multiple President’s Club Awards for his sales achievements. His ability to overcome resistance and gain buy-in from opinion leaders has been instrumental in his career success.